Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat vs Darbepoetin alfa for anemia in dialysis-dependent CKD
NCT02892149Phase 3Completed
- Sponsor
- Akebia Therapeutics
- Start
- Aug 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of vadadustat in anemia of chronic kidney disease (CKD-A), sponsored by Akebia Therapeutics. Started Aug 2016; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02892149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02892149.